Gastroenterology clinical trials recruiting in Pennsylvania

62 recruiting gastroenterology trials match in Pennsylvania. Showing 20.

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Recruiting

  Phase 2 · Sanofi · Uniontown, Pennsylvania

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Harrisburg, Pennsylvania

• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenRecruiting

  Phase 2 · AbbVie · Pittsburgh, Pennsylvania

• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Oklahoma City, Oklahoma

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Uniontown, Pennsylvania

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Harrisburg, Pennsylvania

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruiting

  Phase 3 · Akero Therapeutics, Inc · Hershey, Pennsylvania

• COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)Recruiting

  N/A · University of North Carolina, Chapel Hill · Pittsburgh, Pennsylvania

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Philadelphia, Pennsylvania

• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseRecruiting

  Phase 4 · Takeda · Wexford, Pennsylvania

• Rezdiffra Pregnancy and Lactation RegistryRecruiting

  N/A · Madrigal Pharmaceuticals, Inc. · West Conshohocken, Pennsylvania

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Philadelphia, Pennsylvania

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Philadelphia, Pennsylvania

• Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruiting

  Phase 2 · Diwakar Davar · Pittsburgh, Pennsylvania

• Abbott Cephea Mitral Valve Disease RegistryRecruiting

  N/A · Abbott Medical Devices · Pittsburgh, Pennsylvania

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Hershey, Pennsylvania

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Flourtown, Pennsylvania

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting

  Phase 1 · National Cancer Institute (NCI) · Pittsburgh, Pennsylvania

• NASH AMPK Exercise Dosing (AMPED) TrialRecruiting

  N/A · Milton S. Hershey Medical Center · Hershey, Pennsylvania

• Inflammatory Bowel Disease (IBD) Research RegistryRecruiting

  N/A · University of Pittsburgh · Pittsburgh, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.